Cargando…

Retrospective Review of MET Gene Mutations

C-MET proto-oncogene is a tyrosine kinase situated on chromosome 7. C-MET and its ligand hepatocyte growth factor/scatter factor (HGF/SF) play a role in proliferation, differentiation and organ development. C-MET genetic aberrations are found associated with driving tumorigenesis. In this retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zenali, Maryam, deKay, James, Liu, Zesheng, Hamilton, Stanley, Zuo, Zhuang, Lu, Xinyan, Bakkar, Rania, Mills, Gordon, Broaddus, Russell
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468339/ https://www.ncbi.nlm.nih.gov/pubmed/26097886

Ejemplares similares

A Previously Undescribed Presentation of Mixed Adenoneuroendocrine Carcinoma
por: De Luca-Johnson, Javier, et al.
Publicado: (2016)

Persistent Pain After Lithotripsy
por: Jones, Ellen, et al.
Publicado: (2015)

CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence
por: Kurnit, Katherine C., et al.
Publicado: (2017)

Microcystic/Reticular Schwannoma of the Frontal Lobe: An Unusual Occurrence
por: Pearson, Lauren, et al.
Publicado: (2017)

Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study
por: Liu, Li, et al.
Publicado: (2021)

Clinical Assessment of PTEN Loss in Endometrial Carcinoma: Immunohistochemistry Out-Performs Gene Sequencing
por: Djordjevic, Bojana, et al.
Publicado: (2012)

Acquired Resistance to Osimertinib Plus Savolitinib Is Mediated by MET-D1228 and MET-Y1230 Mutations in EGFR-Mutated MET-Amplified Lung Cancer
por: Piper-Vallillo, Andrew J., et al.
Publicado: (2020)

MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer
por: Ramesh, Shrey, et al.
Publicado: (2023)

A MetAP2 inhibitor blocks adipogenesis, yet improves glucose uptake in cells
por: Siddik, Md Abu Bakkar, et al.
Publicado: (2019)

A Composite Renal Tumor with Dual Differentiation, Chromophobe and Collecting Duct Carcinoma
por: Pearson, Lauren, et al.
Publicado: (2018)

Differential Pattern of Resistance and Sensitivity to Different Classes of MET Inhibitors for MET-Amplified Tumors With MET-D1228X or MET-Y1230X Mutations
por: Piper-Vallillo, Andrew J., et al.
Publicado: (2021)

MET mutation causes muscular dysplasia and arthrogryposis
por: Zhou, Hang, et al.
Publicado: (2019)

Exon 3 mutations of CTNNB1 drive tumorigenesis: a review
por: Gao, Chao, et al.
Publicado: (2017)

Trichodysplasia Spinulosa in a 71-Year-Old Heart Transplant Recipient
por: Dhandha, Maulik M, et al.
Publicado: (2023)

Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer
por: Piguet, Anne-Christine, et al.
Publicado: (2015)

OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets
por: Madden, Stephen F, et al.
Publicado: (2014)

The Impact of Mutation of Myelodysplasia-Related Genes in De Novo Acute Myeloid Leukemia Carrying NPM1 Mutation †
por: Wang, Yi, et al.
Publicado: (2022)

Activating mutation in MET oncogene in familial colorectal cancer
por: Neklason, Deborah W, et al.
Publicado: (2011)

MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit
por: Jardim, Denis L. Fontes, et al.
Publicado: (2014)

Case Report: Sequential Combination Targeted Therapy With Type I and II MET Inhibitors in a Metastatic EGFR-Mutated, MET-Amplified NSCLC Patient With Acquired MET Y1230H Mutation
por: Cai, Boning, et al.
Publicado: (2021)

Devil in the detail: MET overexpression fails as surrogate marker for MET exon 14 splice site mutations in NSCLC
por: Strickland, Matthew R., et al.
Publicado: (2020)

An In silico Approach towards Finding the Cancer-Causing Mutations in Human MET Gene
por: Laskar, Fayeza Sadia, et al.
Publicado: (2023)

Atypical asymmetric lattice corneal dystrophy associated with a novel homozygous mutation (Val624Met) in the TGFBI gene
por: Afshari, Natalie A., et al.
Publicado: (2008)

Correlation of MET-Receptor Overexpression with MET Gene Amplification and Patient Outcome in Malignant Mesothelioma
por: Santoni-Rugiu, Eric, et al.
Publicado: (2021)

Predicting high-risk endometrioid carcinomas using proteins
por: Du, Di, et al.
Publicado: (2018)

MET exon 14 skipping mutations and gene amplification in a Taiwanese lung cancer population
por: Lung, Jrhau, et al.
Publicado: (2019)

A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations
por: Santarpia, Mariacarmela, et al.
Publicado: (2021)

Comprehensive analysis of MET mutations in NSCLC patients in a real-world setting
por: Ai, Xinghao, et al.
Publicado: (2022)

Germline Met Mutations in Mice Reveal Mutation- and Background-Associated Differences in Tumor Profiles
por: Graveel, Carrie R., et al.
Publicado: (2010)

Characterizing the roles of Met31 and Met32 in coordinating Met4-activated transcription in the absence of Met30
por: Carrillo, Emilio, et al.
Publicado: (2012)

Aspergillus Thyroiditis: A Complication of Respiratory Tract Infection in an Immunocompromised Patient
por: Alvi, Madiha M., et al.
Publicado: (2013)

MET immunochemistry: a reliable screening tool for MET exon 14 skipping mutations in non-small cell lung cancer?
por: Pruis, Melinda A., et al.
Publicado: (2020)

Capmatinib in Japanese patients with MET exon 14 skipping–mutated or MET‐amplified advanced NSCLC: GEOMETRY mono‐1 study
por: Seto, Takashi, et al.
Publicado: (2021)

CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases
por: Tan, Yi-Hung Carol, et al.
Publicado: (2010)

The Relationship Between IDH1 Mutation Status and Metabolic Imaging in Nonenhancing Supratentorial Diffuse Gliomas: A (11)C-MET PET Study
por: Kudulaiti, Nijiati, et al.
Publicado: (2019)

Nuclear β-Catenin Localization and Mutation of the CTNNB1 Gene: A Context-Dependent Association
por: Kim, Grace, et al.
Publicado: (2018)

Efficacy and Tolerability of ALK/MET Combinations in Patients With ALK-Rearranged Lung Cancer With Acquired MET Amplification: A Retrospective Analysis
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2023)

cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer
por: Sohn, Joohyuk, et al.
Publicado: (2014)

Lymphoid cell rich fine-needle aspirations of the salivary gland: What is the risk of malignancy?
por: Krishnan, Vimal, et al.
Publicado: (2023)

MET Mutation Is a Potential Therapeutic Target for Advanced Endometrial Cancer
por: Yeh, Yu-Min, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_63e0q5a3fr93qpva0dikhqp52r